Inclusion Criteria : 
  1.  Patients evaluated for residual or recurrent gliomas after initial tumor surgery , external beam radiation and / or chemotherapy with temozolamide. 
  2.  Male and female
  3.  Ages 18 to 70 
Exclusion Criteria : 
  1.  Patient diagnosis with glioma but before surgery , external beam radiation and / or chemotherapy with temozolamide. 
  2.  Women who were pregnant , breast feeding , or possibly pregnant. 
  3.  Patients with hepatic or renal dysfunction. 
  4.  Patients with MRI contraindications ( i. e.  pacemakers , non - MR compatible devices ) . 
  5.  Patients with a history of drug hypersensitivity to 18 F - Fluciclovine.